PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
1. December 2023

Webinar: How to diagnose Occlusion Myocardial Infarction (OMI) with ECG

The “Beyond STEMI: Diagnose Acute Coronary Occlusion Myocardial Infarction (OMI) with ECG” webinar was a highly anticipated event for healthcare professionals. Featuring experts Dr. Stephen W. Smith, Dr. H. Pendell Meyers, and Dr. Robert Herman, this webinar offered insights into the (Occlusion Myocardial Infarction) OMI Paradigm, demonstrating its superiority over traditional STEMI criteria in diagnosing Acute Coronary Occlusion.

Learn how to diagnose acute coronary Occlusion Myocardial Infarction (OMI) with ECG (Powerful Medical Webinar)

The Urgent Need for the OMI Paradigm

The current STEMI criteria often overlook patients needing urgent cardiac care, particularly those with acute coronary occlusion who do not have typical ST elevation on the ECG. Embracing the OMI/NOMI Paradigm can significantly improve the timeliness and sensitivity of acute coronary occlusion detection, thereby saving critical hours and reducing the mortality of cardiovascular patients.

AI-Driven Advancements in ECG Interpretation: The Queen of Hearts Model

Emerging as a tool developed to meet the challenges of the OMI Paradigm, the Queen of Hearts within the PMcardio app excels at detecting subtle OMI patterns, which are crucial for the early and accurate detection of Acute Coronary Occlusion, enabling prompt intervention and saving critical hours. Notably, PMcardio is the first CE-certified medical device of its kind, currently awaiting FDA certification. This recognition reflects its potential to transform cardiac care globally, making the advanced diagnostic tool more accessible to healthcare professionals worldwide.

Educational Challenges in Cardiology

The webinar emphasised the necessity of thorough ECG analysis in patients presenting with chest pain, particularly considering ECG findings such as hyperacute T waves and their relation to the preceding QRS complex, Aslanger pattern, and subtle ST depression, among other signs. This highlights the importance of in-depth ECG interpretation for accurate diagnosis. Additionally, the discussion addressed the need to educate physicians to look beyond traditional STEMI criteria in the assessment of acute coronary events syndrome.

Conclusion

This webinar served as an educational session, showing healthcare professionals how to adopt the OMI Paradigm in their practice. By integrating this approach, alongside AI advancements like the Queen of Hearts model, practitioners can significantly enhance the accuracy and early detection of acute coronary occlusion regardless of ST elevation. This shift towards a more inclusive and advanced diagnostic framework promises to revolutionise patient care in cardiology.

If you couldn’t attend the live session, we’ve got you covered. Watch the full webinar on our YouTube channel, to catch up on these essential insights and be part of this important shift in cardiology practice.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

Share this article

Don't miss these

Image is showing logos of the two companies mentioned in the text - PMcardio and Alphaiota

Alphaiota Expands Strategic Partnership with PMcardio to Launch First AI-Powered Heart Attack Diagnostic Platform in Saudi Arabia

Alphaiota and PMcardio announce the expansion of their strategic partnership to bring the first AI-powered heart attack diagnostic solution to the Kingdom of Saudi Arabia. Developed by Powerful Medical, a medical device manufacturer specializing in AI-driven cardiovascular diagnostics, PMcardio will be introduced by Alphaiota as the exclusive distributor in the region, marking a first-of-its-kind deployment in the Middle East.
Image ilustrating the VAIA grant reception containing logos of important public institutions

Powerful Medical Awarded €1M EU-Funded Grant by Slovak Ministry of Economy to Advance AI-ECG Heart Attack Diagnostics

Powerful Medical has received over €985,000 in funding from the Slovak Ministry of Economy, as part of the EU-funded Recovery and Resilience Plan. The grant supports the continued development of our AI-based ECG interpretation technology, focused on improving early diagnosis and treatment of acute coronary syndromes (ACS).

Join over 100,000 healthcare professionals who are already taking advantage of AI